GP Vivas · respiratory-health
Chronic cough — structured viva
Structured oral on chronic cough: the systematic evaluation through UACS, asthma and GORD, ACE-inhibitor cough evidence, PPI trial limits per Cochrane, refractory chronic cough concept and speech pathology/gabapentin options.
On this page
Study tools
Target exams
RACGP CCEFRACGP oralsMRCGP SCA
Prompt
The examiner opens: 'A patient has had a cough for three months — just give them a trial of everything.' You are asked to present the systematic approach instead.
Stem
The examiner asks how you approach a patient with a cough lasting more than eight weeks. [1]
References5ShowHide
- [1]Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev, 2011.PMID 21249664
- [3]Irwin RS, French CL, Chang AB, et al. Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report. Chest, 2018.PMID 29080708
- [4]Ribeiro VV, Casmerides MCB, da Silva Reis ZMC, de Santana ÍV, do Carmo RD, Behlau M Efficacy of Speech-language Pathology Therapy in Chronic Cough: Systematic Review With Meta-analysis. J Voice, 2024.PMID 34969556
- [5]Hu Y, Liang L, Liu S, Kung JY, Banh HL Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta-analysis. J Clin Hypertens (Greenwich), 2023.PMID 37417783
- [6]Salois JR, Heinle KL, Slovarp LJ, Jetté ME, Manchaiah V, et al. Internet-Based Behavioral Cough Suppression Therapy for Refractory Chronic Cough: A Randomized Controlled Trial. Am J Speech Lang Pathol, 2025.PMID 40811675